Göksel, S. Et Al. 2021. Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer. Journal Of Cancer Research And Therapeutics , vol.17 , 925-930.

Göksel, S., Cengiz, A., Öztürk, H., & Yürekli, Y., (2021). Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer. Journal Of Cancer Research And Therapeutics , vol.17, 925-930.

Göksel, SİBEL Et Al. "Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer," Journal Of Cancer Research And Therapeutics , vol.17, 925-930, 2021

Göksel, SİBEL Et Al. "Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer." Journal Of Cancer Research And Therapeutics , vol.17, pp.925-930, 2021

Göksel, S. Et Al. (2021) . "Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer." Journal Of Cancer Research And Therapeutics , vol.17, pp.925-930.

@article{article, author={SİBEL GÖKSEL Et Al. }, title={Prognostic impact of the 18F‑fluorodeoxyglucose positron‑emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer}, journal={Journal Of Cancer Research And Therapeutics}, year=2021, pages={925-930} }